ACNN.F Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
AusCann Group Holdings Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
ACNN.F Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AusCann Group Holdings Ltd Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
- -0.021
- 82.23%
- -693.75%
- 0%
About ACNN.F
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann’s Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia.
